BriaCell Therapeutics Corp. (BCTX): Capital Expenditures

Annual figures by period end, from SEC filings.

$127.0K
Year ended 2026-07-31
$456.8K2024-07-31: $456.8K2026-07-31: $127.0K$127.0K
2024-07-31 Capital Expenditures (USD) 2026-07-31
Period endedCapital ExpendituresChange YoYSource filing
2026-07-31$127.0Kn/a2026-10-28, From 2025-08-01
No annual figure between 2024-07-31 and 2026-07-31.
2024-07-31$456.8Kn/a2025-10-16, From 2023-08-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
BriaCell Therapeutics Corp. (BCTX)2026-07-31$127.0Kn/a
Immunic, Inc. (IMUX)2025-12-31$161.0K-39.0%
Kiora Pharmaceuticals Inc (KPRX)2025-12-31$110.8Kn/m
Faeth Therapeutics, Inc. (FTH)2025-12-31$16.0K-89.0%
HCW Biologics Inc. (HCWB)2025-12-31$0-100.0%
Moleculin Biotech, Inc. (MBRX)2025-12-31$0-100.0%
Integrated Biopharma Inc (INBP)2026-06-30$346.0K+81.2%
CASI Pharmaceuticals, Inc. (CASIF)2025-12-31$16.0K-92.8%
Elicio Therapeutics, Inc. (ELTX)2025-12-31$16.0K-81.6%

Compare BCTX, IMUX, KPRX, FTH side by side · Screen every company in Pharmaceutical Preparations ↗